What are the payment terms for this product?

Terms of payment include LC (Letter of Credit), T/T (Telegraphic Transfer), and D/P (Documents against Payment).

What is the lead time for production?

The average lead time is 1-3 months for both peak season and off-season periods.

Can I get OEM or ODM services?

Yes, the manufacturer offers both OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) services.

Pharmaceutical 1g Ceftriaxone Sodium for Injection and 10ml Water for Injection

Name: Pharmaceutical 1g Ceftriaxone Sodium for Injection and 10ml Water for Injection
Brand: REYOUNG PHARMACEUTICAL CO., LTD.
SKU: 785611372

Shandong, ChinaREYOUNG PHARMACEUTICAL CO., LTD.

US$0.25

100,000 box

Sample price:US$2.00/box.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

Im/IV Injection

Model NO.

1g+10ml

Suitable for

Elderly, Children, Adult

State

Solid

Shape

Powder

Type

Organic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

Lu20160062

Drug Ad Approval No.

Lu20160062

Certificate

GMP, SGS, ISO

Transport Pagage

Carton

Transport

by Sea, by Air, by Land

Unit of Quantity

Box

Transport Package

1+1 Vials/Box

Specification

1g+10ml

Trademark

Reyoung

Origin

China

HS Code

3003909090

Production Capacity

5millions

Key features

Broad-Spectrum Antibiotic: Third-generation cephalosporin effective against respiratory, urinary, and systemic bacterial infections.

Once-Daily Dosing: Long half-life allows convenient once-daily administration for both inpatient and outpatient settings.

High CSF Concentration: Achieves high concentrations in cerebrospinal fluid, making it a first-line choice for bacterial meningitis.

GMP & ISO Certified: Manufactured in GMP, ISO9001, ISO14001 authenticated facilities with strict quality control.

Global Export Experience: Exported to over 100 countries with certifications from EU, Brazil, Mexico, and UNICEF.

Large Production Capacity: Annual capacity of 1.5 billion vials of powder for injection across 41 workshops.

Custom Packaging Options: Transport packaging available in cartons, with GMP, SGS, and ISO certificates provided.

Established Manufacturer: Leading Chinese pharmaceutical manufacturer established in 1966 with over 5,000 staff.

Company profile

REYOUNG PHARMACEUTICAL CO., LTD.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 1997-01-01 CertifiedNearest Port: Qingdao PortAverage Response Time: ≤24h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryREYOUNG PHARMACEUTICAL CO., LTD. is a China-based limited company established in 1998, with 4,950 employees and operations in Shandong. The supplier reports ISO 9001, ISO 14001, and OHSAS 18001 certifications, more than 10 production lines, 50 quality-control staff, and 370 years of combined R&D-engineer experience. Its stated manufacturing portfolio includes sterile raw materials, powders and liquids for injection, tablets, and capsules, with reported annual production above the stated threshold. The company identifies three factories, an extensive manufacturing area, international business since 1997, and export markets across South America, Africa, Southeast Asia, and the Middle East. Trade records show transactions involving India, Bolivia, and Vietnam, including cefotaxime-related products. Evidence is insufficient to assess after-sales service, financial credibility, innovation output, or customization capability. Customer-case evidence is limited to named buyers and trade records.

Supplier typeThe supplier is identified as a combined business entity and a limited company headquartered in Shandong, China. Its business scope is health and medicine, with products including sterile raw materials, injectable products, tablets, and capsules, supporting classification as a pharmaceutical manufacturer and distributor.

CertificationsThe supplier explicitly reports ISO 9001:2015, ISO 14001:2015, and OHSAS 18001:2007 certificates, and separately describes itself as GMP and ISO authenticated. These stated certifications provide direct evidence of formal quality, environmental, and occupational-health management systems.

Production capacityProduction capacity is supported by more than 10 production lines, three factories, a reported manufacturing area of 1,000,000 square meters, and stated annual output across small-volume injections, powder injections, tablets, and capsules. The supplier also reports annual production above the stated threshold, indicating substantial multi-form pharmaceutical manufacturing capability.

Client casesTrade records identify transactions involving STERILE INDIA PRIVATE LIMITED, HEREDIA ARACENA RENY EVELIN, and a Vietnam-related registration, with products including cefotaxime-related material and oral rehydration products. These records demonstrate some international commercial activity, but the evidence is limited and does not establish long-term customer performance or a broad verified customer portfolio.

Product Q&A

Q:What infections does Ceftriaxone Sodium treat?

It treats respiratory tract infections, UTIs, intra-abdominal infections, skin/soft tissue/bone/joint infections, serious systemic infections like sepsis and meningitis, and gonorrhea.

Q:How is Ceftriaxone Sodium administered?

It is administered via Intramuscular (IM) or Intravenous (IV) injection as a powder for injection.

Q:Is Ceftriaxone suitable for children and the elderly?

Yes, it is suitable for elderly, children, and adults. It is a first-line choice for bacterial meningitis in both adults and children.

Q:What is the dosing frequency for Ceftriaxone?

Due to its long half-life, it allows for once-daily dosing in most indications, making it convenient for treatment.

Q:What certifications does the manufacturer hold?

The manufacturer is GMP, ISO9001, ISO14001, and OHS18001 authenticated, with additional inspections passed by EU, Brazil, Mexico, and others.